FDA Approves Blood Test Developed by Abbott, USAMMDA for Traumatic Brain Injury
The U.S. Food and Drug Administration recently approved a blood test the U.S. Army Medical Materiel Development Activity at Fort Detrick worked on with Abbott Point of Care, which can detect signs of traumatic brain injury more quickly than a previous test by UF startup Banyan Biomarkers. Banyan's biomarkers are used in the new device.
Abbott Blood Test To Evaluate Mild Concussions Wins FDA Clearance
Doctors soon will have a new way to evaluate patients with concussions: a rapid blood test made by Abbott Laboratories that has been cleared by the U.S. Food and Drug Administration. It’s an advancement that could eliminate the need for some patients to get costly CT scans and the radiation exposure that accompanies them.
